0000899243-19-017843.txt : 20190621
0000899243-19-017843.hdr.sgml : 20190621
20190621173351
ACCESSION NUMBER: 0000899243-19-017843
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190619
FILED AS OF DATE: 20190621
DATE AS OF CHANGE: 20190621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Corvese Brian
CENTRAL INDEX KEY: 0001393207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 19912611
MAIL ADDRESS:
STREET 1: C/O ANTIGENICS INC.
STREET 2: 162 FIFTH AVENUE, SUITE 900
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-19
0
0001098972
AGENUS INC
AGEN
0001393207
Corvese Brian
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
1
0
0
0
Stock Option, Right to buy
2.38
2019-06-19
4
A
0
2500
0.00
A
2020-01-01
2029-01-01
Common Stock
2500
2500
D
Stock Option, Right to buy
2.38
2019-06-19
4
A
0
100000
0.00
A
2020-01-01
2029-01-01
Common Stock
100000
102500
D
Restricted Stock Unit
2019-06-19
4
A
0
27118
A
2020-06-19
Common Stock
27118
27118
D
Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020.
Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020.
/s/Evan D. Kearns, as Attorney-in-Fact for Brian Corvese
2019-06-21